Rui-xiang Xia

218 Jixi Road
Hefei, 230022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.

N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.

Journal: Molecular and cellular biochemistry

Published: August 18, 2023

Effect of rhTPO and rhIL-11 on Thrombocytopenia after Chemotherapy in Leukemia

Effect of rhTPO and rhIL-11 on Thrombocytopenia after Chemotherapy in Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: June 10, 2022

LncRNA FIRRE stimulates PTBP1-induced Smurf2 decay, stabilizes B-cell receptor, and promotes the development of diffuse large B-cell lymphoma.

LncRNA FIRRE stimulates PTBP1-induced Smurf2 decay, stabilizes B-cell receptor, and promotes the development of diffuse large B-cell lymphoma.

Journal: Hematological oncology

Published: January 18, 2022

Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis.

Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis.

Journal: Leukemia research

Published: January 14, 2021

Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia.

Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia.

Journal: Leukemia research

Published: January 14, 2021

CDK12 activates MYC to repress miR-28-5p/EZH2 and amplifies tonic BCR signaling to promote the development of diffuse large B-cell lymphoma.

CDK12 activates MYC to repress miR-28-5p/EZH2 and amplifies tonic BCR signaling to promote the development of diffuse large B-cell lymphoma.

Journal: Cancer gene therapy

Published: January 05, 2021

Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML).

Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML).

Journal: European journal of pharmacology

Published: November 11, 2020

Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia.

Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia.

Journal: Experimental cell research

Published: November 19, 2019

Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.

Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.

Journal: Biochemical and biophysical research communications

Published: June 06, 2018

Clinical significance of measuring reticulated platelets in infectious diseases.

Clinical significance of measuring reticulated platelets in infectious diseases.

Journal: Medicine

Published: February 01, 2018

Expression of CXCR7 in Acute Monocytic Leukemia and Its Effects on THP-1 Cell Functions

Expression of CXCR7 in Acute Monocytic Leukemia and Its Effects on THP-1 Cell Functions

Journal: Zhongguo shi yan xue ye xue za zhi

Published: October 27, 2017

Value of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio for Prognostic Evaluation of Diffuse Large B-cell Lymphoma

Value of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio for Prognostic Evaluation of Diffuse Large B-cell Lymphoma

Journal: Zhongguo shi yan xue ye xue za zhi

Published: May 07, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026